Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease

NCT00543374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Placebo
DRUG: PROCHYMAL adult human mesenchymal stem cells

Sponsor

Mesoblast, Inc.